Results 31 to 40 of about 13,175 (219)
Journal of Orofacial Sciences, 2023 Introduction: Chemerin is a multifunctional chemoattractant cytokine, encoded by RARRES2 gene. Its role in oral carcinogenesis is largely unexplored. Study was undertaken to evaluate the role of salivary chemerin as a potential biomarker in the early ...
Karthika Pradeep Susha, Rathy Ravindran
doaj +1 more source
Feasibility of recruitment to an oral dysplasia trial in the United Kingdom [PDF]
, 2012 Background: Oral epithelial dysplasia (OED) has a malignant potential. Therapeutic options for OED remain both limited and without good evidence. Despite surgery being the most common method of treating OED, recurrence and potentially significant ...
Nankivell, Paul +11 more
core +1 more source
Oral Leukoplakia – Is Biopsy at the Initial Appointment a Must? [PDF]
Journal of Clinical and Diagnostic Research, 2014 Background: Oral leukoplakia is a potentially malignant disorder of the oral cavity. Leukoplakias with chances of undergoing malignant transformation owing to the presence of dysplastic changes may not be clinically distinguishable from leukoplakias ...
Sunil Mutalik +4 more
doaj +1 more source
Immunohistochemical Evaluation of EGFR Expression in Oral Dysplastic and Non-Dysplastic Leukoplakia [PDF]
Journal of Mashhad Dental School, 2023 Background: This study aimed to evaluate the expression of epidermal growth factor receptor (EGFR) in oral leukoplakia with and without dysplasia and normal mucosa by immunohistochemistry.Materials and Methods: In this study, 45 samples of oral ...
Nasrollah Saghravanian +3 more
doaj +1 more source
Critical Reviews in Oral Biology & Medicine, 1995 Leukoplakia has evolved as a clinico-pathologic concept over many years, with the current clinical designation being accepted worldwide. Reflective of the biology of leukoplakia is the concept of cellular atypia and epithelial dysplasia. Adding to a better understanding of leukoplakia in general has been the definition of relevant clinical subsets ...
openaire +2 more sources
Chemoprevention in oral leukoplakia: challenges and current landscape
Frontiers in Oral Health, 2023 Oral potentially malignant disorders have the potential to transform into oral cancer. Oral leukoplakia is a prevalent OPMD with a 9.8% malignant transformation rate.
Victor de Mello Palma +5 more
doaj +1 more source
Oral leukoplakia; a proposal for simplification and consistency of the clinical classification and terminology [PDF]
, 2019 There is a distinct lack of uniformity in the definitions and clinical terminologies related to oral leukoplakia and leukoplakialike lesions and disorders.
Waal, Isaäc Van der +2 more
core +1 more source
Immunoexpression of Podoplanin in Leukoplakia and Oral Squamous Cell Carcinoma and its Correlation with Survival: A Research Protocol [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Podoplanin (PDPN) is a well-conserved mucin-type transmembrane glycoprotein. According to various studies, podoplanin expression is seen in various human cancers and it also encourages the progression of the tumour.
Samiha Jameel Ahmed Khan +4 more
doaj +1 more source
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source
Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia
Molecular Cancer, 2007 Background Oral leukoplakia is a precancerous change developed in the oral mucosa, and the mechanism that oral leukoplakia becomes malignant through atypical epithelium is not known.
Hata Tsuyoshi +6 more
doaj +1 more source